Search Results - SIVIK, Tove

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer

    17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer by JANSSON, Agneta K, GUNNARSSON, Cecilia, COHEN, Maja, SIVIK, Tove, STAL, Olle

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer

    17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer by Sivik, Tove, Gunnarsson, Cecilia, Fornander, Tommy, Nordenskjöld, Bo, Skoog, Lambert, Stål, Olle, Jansson, Agneta

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D

    Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D by Sivik, Tove, Jansson, Agneta

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

    C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients by Hilborn, Erik, Sivik, Tove, Fornander, Tommy, Stål, Olle, Nordenskjöld, Bo, Jansson, Agneta

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    17[beta]-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer

    17[beta]-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer by Sivik, Tove, Gunnarsson, Cecilia, Fornander, Tommy, Nordenskjöld, Bo, Skoog, Lambert, Stål, Olle, Jansson, Agneta

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 3142: Expression of C-X-C motif chemokine 10 (CXCL10) in breast cancer

    Abstract 3142: Expression of C-X-C motif chemokine 10 (CXCL10) in breast cancer by Sivik, Tove, Kot, Agnieszka, Stål, Olle, Fornander, Tommy, Skoog, Lambert, Nordenskjöld, Bo, Jansson, Agneta

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    17{beta}-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor-Positive Breast Cancer

    17{beta}-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor-Positive Breast Cancer by Jansson, Agneta K, Gunnarsson, Cecilia, Cohen, Maja, Sivik, Tove, Staal, Olle

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer

    17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer by Jansson, Agneta K, Gunnarsson, Cecilia, Cohen, Maja, Sivik, Tove, Stål, Olle

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: